Kyndryl Holdings recently announced an expanded partnership with Google Cloud, focusing on using generative AI to modernize mainframe applications. Despite these positive announcements, including being a certified partner for Google Cloud's AI models, Kyndryl's stock fell 14% last week, aligning with broader market declines amid heightened trade tensions and the ongoing tariff challenges affecting global markets. While Kyndryl's financial steps, like the new revolving credit agreement, bolster its financial footing, these developments could not counteract broader market pressures, as seen by the Dow Jones and S&P 500 dropping significantly during the same period.

We've spotted 2 possible red flags for Kyndryl Holdings you should be aware of, and 1 of them is concerning.

The end of cancer? These 23 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

Over the past three years, Kyndryl Holdings' shares have delivered a remarkable total return of 129.31%. In comparison, over the last year, the company outperformed both the US market and the US IT industry, each of which saw a 5.8% decline. Despite these positive longer-term returns, recent short-term challenges have weighed on the stock, with a notable 14% drop in the past week following global market pressures.

The expanded partnership with Google Cloud has the potential to benefit Kyndryl's revenue and earnings forecasts by enhancing its service offerings and driving modernization projects. However, the recent market downturn and emerging trade tensions have contributed to immediate pressure on the stock price. The current share price reflects a significant discount—about 60.6%—to the consensus analyst price target of US$44.60, suggesting potential positive sentiment among analysts regarding the company's future performance despite recent declines.

Examine Kyndryl Holdings' past performance report to understand how it has performed in prior years.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NYSE:KD.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com